Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stayhealthy.com: Monitoring your wellness on the Web -- Ignore unavailable to you. Want to Upgrade?

To: Eric Fader who wrote (1075)	12/28/2000 10:20:58 AM
From: Ted M	Read Replies (2) \| Respond to of 3785

News--I recall that these are the folks with rather high product prices.. Thursday December 28, 8:01 am Eastern Time Press Release CYBeR-CARE Announces FDA Approval For Blood Glucose Monitoring System - Glucometer ATLANTA--(BW HealthWire)--Dec. 28, 2000--CYBeR-CARE, Inc. (Nasdaq:CYBR - news), the telehealth technology innovator, recently received clearance from the FDA to market its Blood Glucose Monitoring System (Glucometer). The Glucometer will be integrated with the Electronic HouseCall(TM) System family of products and will provide the industry with an economically priced tool with several technological advantages over current industry offerings. Packet technology benefits system users by simultaneously transmitting data received from the Glucometer along with voice and visual information. All information is received in real-time by the caregiver and is available to payors and caregivers through the secure CYBeR-CARE network. Caregivers can measure results against historical data, from the Glucometer and other monitoring tools available on the Electronic HouseCall System to enable them to deliver better care and more effective disease management treatment. ``We are pleased to be able to announce the FDA approval for our electronic Blood Glucose Monitoring System,'' said Mike Lemnitzer, Vice President of Business Development, CyberCare Technologies. ``This tool significantly expands our target market by allowing the at home remote monitoring of the diabetic patient.'' According to the American Diabetes Association, there are 15.7 million diabetics in the U.S., of which 5.4 million are undiagnosed. The product underwent clinical trials at the nationally renowned Shepherd Center, a specialty hospital located in Atlanta, and will be available for shipment in January. About CYBeR-CARE, Inc. CyberCare Technologies is a subsidiary of CYBeR-CARE, Inc. Based in Boynton Beach, FL, CYBeR-CARE is a network company with a patented Internet-based technology system that provides for the remote monitoring of individuals for health care purposes. The Company also has physical, occupational and speech therapy centers and an institutional pharmacy. CYBeR-CARE can be found on the Web at cyber-care.net. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. -------------------------------------------------------------------------------- Contact: Duffey Communications, Atlanta Media Contact: Jean Hodges/Denise Garner, 404/266-2600 jhodges@duffey.com dgarner@duffey.com